**Frequently Asked Questions**
**What is KESIMPTA?**
KESIMPTA (ofatumumab) is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
**How often do I take KESIMPTA?**
You start with weekly injections for the first three weeks, then take it once a month. KESIMPTA is the only B-cell treatment for relapsing MS you can take at home once a month after the starter doses.
**Can I give myself KESIMPTA injections at home?**
Yes, KESIMPTA can be self-administered at home using either a prefilled syringe or the Sensoready auto-injector pen after proper training.
**How effective is KESIMPTA at reducing relapses?**
In two studies versus teriflunomide, KESIMPTA reduced the annual rate of relapses by 51% and 58%.
**Does KESIMPTA slow disability progression?**
Yes, KESIMPTA reduced disability progression by 34% at 3 months and 32% at 6 months in two studies versus teriflunomide.
**Who should not take KESIMPTA?**
Do not take KESIMPTA if you have an active hepatitis B virus (HBV) infection or have had an allergic reaction to ofatumumab or life-threatening injection-related reaction to KESIMPTA.
**Can a caregiver give me my KESIMPTA injection?**
Yes, a caregiver can administer your injection after receiving proper training from your healthcare provider.
Leave a Reply